Summary

Dr. Buckingham's primary work focuses on diabetes research in children, particularly continuous glucose monitoring and immune intervention for the treatment of type 1 diabetes. He has been conducting clinical trials with various sensors for over 10 years. Currently, he is the Principal Investigator on two multicenter studies of continuous glucose monitoring in children. He also has two grants from JDRF to study algorithm development in creating a closed-loop artificial pancreas. Previously, he was Stanford's PI for the Medtronic Minimed Star 1 trial of the Paradigm CGM system.

Research Focus

Continuous glucose monitoring in children

Development of a closed-loop for management of persons with type 1 diabetes and for use in pediatric intensive care units

Use of immunomodulating drugs to prolong islet function at the onset of diabetes

Diabetes prevention

Education

Dr. Buckingham received his medical degree from University of California at San Diego. He completed his internship, residency, and fellowship at Children's Hospital of Los Angeles.

Recognition

Well known for his expertise in diabetes treatment and technology, Dr. Buckingham has written numerous publications and presented at meetings around the world. He is a member of the American Diabetes Association, currently serves on the Program Committee, and is Chair of the Council on Youth. He is board certified in Pediatrics and Pediatric Endocrinology.

To schedule an interview

TrialNet is a network of 21 Clinical Centers working in cooperation with screening sites throughout the United States, Canada, Finland, United Kingdom, Italy, Germany, Australia, and New Zealand. This network is dedicated to the study, prevention, and early treatment of type 1 diabetes. Learn More >